FDA OKs expanded emergency use of Quidel COVID-19 test

The FDA has amended its Emergency Use Authorization for Quidel’s (OTC:QDEL) rapid point-of-care Sofia SARS Antigen FIA test to allow it to be run on its automated Sofia Fluorescent Immunoassay Analyzer that can generate results in as little as 15 minutes.
https://seekingalpha.com/news/3581808-fda-oks-expanded-emergency-use-of-quidel-covidminus-19-test